| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding | |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | Entrez:608 MIM:109545 HGNC:HGNC:11913 Ensembl:ENSG00000048462 AllianceGenome:HGNC:11913 | |
| Description | TNF receptor superfamily member 17 | |||||
| GTO ID | GTC1935 |
| Trial ID | NCT03602612 |
| Disease | Plasma Cell Myeloma | Multiple Myeloma |
| Altered gene | BCMA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | BCMA CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Active, Not Recruiting |
| Title | T Cells Expressing a Novel Fully-Human Anti-BCMA CAR for Treating Multiple Myeloma |
| Year | 2018 |
| Country | United States |
| Company sponsor | National Cancer Institute (NCI) |
| Other ID(s) | 180125|18-C-0125 |
| Cohort 1 | |||||||||||
|
|||||||||||